It has recently been shown that an idiotypic determinant(s) (460-Id) 1 found on the 2,4-dinitrophenyl (DNP) and 2,4,6-trinitrophenyl (TNP)-binding myeloma protein, MOPC-460, is expressed on some anti-TNP antibodies produced by BALB/c mice after immunization with certain thymus-independent (TI) (1) and thymus-dependent (2) TNP antigens. In vitro studies indicate that the 460-Id-bearing component of the anti-TNP response to the TI antigen, TNP-Nocardia water-soluble mitogen (NWSM), is regulated by a 460-Id-specific suppressor T cell found in the spleen of normal BALB/c mice (1).
pared as previously described (1) . An aminoethylcarbamylmethyl (AECM) derivative of levan, derived from Aerobacter levanicum, was the kind gift of Dr. C. Glaudemans, National Institute of Arthritis, Metabolic and Digestive Diseases, National Institutes of Health, Bethesda, Md. It contained 1 AECM group per 21 sugars. TNP-levan, containing 1 TNP per 24 sugars, was prepared by the reaction of trinitrobenzenesulfonate with AECM-levan.
Myeloma Proteins. , an IgA, x-myeloma protein with DNP-and TNP-binding activity, and EPC-109 and UPC-61, IgA, K-myeloma proteins with fl(2-6), fl(2-1) fructosanbinding activity were kindly donated by Dr. Michael Potter, National Cancer Institute, National Institutes of Health, Bethesda, Md.
Preparation of Anti-Idiotype Antibodies. Anti-460-Id antibodies were prepared by immunization of BALB/c mice with 75/.tg of MOPC-460 myeloma protein emulsified in complete Freund's adjuvant. This was followed 5 d later by a similar dose of myeloma protein in incomplete Freund's adjuvant and then by six weekly injections of 75/~g of protein in saline. Anti-460-Id antibodies were also obtained from a hybridoma [No. 77-14-11-F6(51)] derived by Buttin et al. (3) . These antibodies were used in the radioimmunoassay for 460-Id. Antibodies specific for the idiotypic determinants of anti-460-Id antibodies (anti-[anti-460-Id] antibodies) were produced by immunization of BALB/c mice with purified anti-460-Id antibodies coupled to keyhole limpet hemocyanin (KLH). Anti-460-Id antibodies were purified by absorption of an ammonium sulfate fraction of BALB/c anti-460-Id serum to a Sepharose 4B-MOPC-460 column (Pharmacia Fine Chemicals, Div. of Pharmacia Inc., Piscataway, N. J.) followed by elution with a glycine-HC1 buffer (0.1 M; pH 2.8). The purified antibodies were conjugated to KLH by mixing purified antibody with KLH, at a final concentration of 0.5 mg/ml, in the presence of 0.05% glutaraldehyde. The reaction was allowed to proceed until the solution was opalescent; it was then stopped by the addition of lysine to a final concentration of 0.05 M. This was followed by extensive dialysis. The KLH-anti-460-Id conjugate was then used to immunize BALB/c mice according to the same schedule as that described for immunization with MOPC-460. Anti-E109-Id antibodies were produced in A/He mice as previously described (1).
Antibody Assays. TNP-coated sheep erythrocytes (SRBC) were prepared according to the technique of Rittenberg and Pratt (4). Levan-SRBC were prepared using O-steroyl levan as described by Hammerling and Westphal (5) . MOPC-460-, EPC-109-, and UPC-61-coated SRBC were prepared using the chromic chloride method (6) . Anti-TNP, anti-levan, and anti-460-Id serum antibody titers were determined by agglutination of coated SRBC. The hemagglutinin (HA) titer reported is the log2 of the reciprocal of the highest dilution giving agglutination. Serum 460-Id titers were determined by the capacity of serum and serum dilutions to inhibit the agglutination of MOPC-460-eoated SRBC by anti-460-Id antibodies. The hemagglutination inhibition titer reported is log2 of the reciprocal of the highest dilution of serum which caused inhibition of hemagglutination.
Serum levels of 460-Id were also measured by a radioimmunoassay in which the capacity of serum and serum dilutions to inhibit the binding of 125I-labeled F(ab) fragments of MOPC-460 by hybridoma anti-460-Id antibodies was determined (3). F(ab) fragments of MOPC-460 myeloma protein were prepared according to the techniques of Kuetter et al. (7) and labeled with 12sI through the use of chloramine T (8) . Rabbit anti-mouse Fc antibodies were used to precipitate complexes of MOPC-460 F(ab) fragments and anti-460-Id antibodies. These antiFc antibodies were prepared by immunization of rabbits with two injections of 1 mg each of purified H chains followed by absorption of the serum on an AH-Sepharose column (Pharmacia Fine Chemicals, Div. of Pharmacia Inc.) to which F(ab) fragments ofA/J IgG had been linked (9) . The H chains were purified from pooled A/J IgG by reduction and alkylation, followed by gel filtration on Sephadex G-200 (Pharmaeia Fine Chemicals, Div. of Pharmacia Inc.) equilibrated with 5 M guanidine (10) . F(ab) fragments of A/J IgG were prepared as described by Porter et al. (11) .
Separation of T and B Lymphocytes. Thymus-dependent (T) lymphocytes were purified by passage over nylon wool columns. Of the cells obtained, 95-98% cguld be killed by anti-Thy 1.2 and complement (C) (12) . These cells failed to proliferate in vitro to lipopolysaccharide (LPS) or NWSM. Cell preparations enriched in thymus-independent (B) lymphocytes were obtained by treating spleen cells with anti-Thy 1.2 serum (Litton-Bionetics, Bethesda, Md.) and C as previously described (1). These cells gave in vitro thymidine-incorporation responses to concanavalin A of less than twice background in experiments in which unseparated cells gave responses which were 50-120 times background. The B-cell preparations responded well to LPS and NWSM. Such responses could be abolished by treating B cells with rabbit antimouse Ig and C (13) .
In and levan was determined by a hemolytic plaque assay, as previously described (1, 14) . The percentage of anti-TNP PFC-secreting anti-TNP antibodies carrying the 460-Id and of antilevan PFC-secreting anti-levan antibodies carrying E109-Id was determined by adding BALB/ c anti-460-Id or A/He anti-E109-Id antisera to the agarose, as previously described (14) . The difference between the number of PFC obtained in the absence and presence of anti-Id represents the number of PFC-secreting antibody bearing the Id under study. The standard error of these numbers of PFC-secreting Id-bearing antibodies is SE ---~/SE21 + SE22, in which SE1 is the SE of the number of PFC in absence of anti-Id sera, and SE2 is the SE of the number of PFC in the presence of anti-Id sera.
The number of direct and indirect PFC-secreting antibody specific for MOPC-460 was determined using MOPC-460-coated SRBC.
Results

Production of Syngeneic Anti-460oId Antibodies in BALB/c Mice.
To determine whether the production of anti-TNP antibodies expressing 460-Id could be influenced by pretreatment with anti-460-Id antibodies, or by a state of active immunity to 460-Id determinants, we immunized BALB/c mice with MOPC-460, as described in Materials and Methods. Such mice developed antibodies which agglutinated MOPC-460-coated SRBC, but not MOPC-167-coated SRBC (Table I A) . Because both MOPC-460 and MOPC-167 are IgA, I¢-myeloma proteins, this result indicates that a syngeneic anti-460-Id antibody response has occurred and confirms a previous report by Sakato and Eisen (15) . Furthermore, these immune animals have splenic PFC specific for MOPC-460, but not for U-61 as shown by selective lysis of MOPC-460-coated SRBC (Table I B ) and selective inhibition of this lysis by MOPC-460 (Table I C) .
Influence of Anti-460-Id Antibodies on Production of 460-Id + Anti-TNP Antibodies. We have previously shown that a small but significant fraction of anti-TNP antibodies produced by BALB/c mice in response to immunization with TNP-NWSM carry 460-Id determinants. In the experiment illustrated in Table II, 23% of specific for anti-460-Id-coated SRBC (Id-3 mice) were immunized with either TNP-NWSM or TNP-levan. These mice produced an anti-TNP antibody response in which the 460-Id + component was substantially increased as compared to normal BALB/c mice immunized with the same TNP antigens (Table III) . Thus, of the anti-TNP PFC produced by Id-3 mice immunized with TNP-levan, 34% could be inhibited with anti-460-Id, whereas only 12% of the anti-TNP PFC produced by normal BALB/ c mice immunized with TNP-levan were inhibitable. The P value for the difference of these values was < 0.005. A similar difference was observed in the anti-TNP response to TNP-NWSM, although it did not reach levels of statistical significance. In addition, serum concentration of 460-Id molecules were also higher in Id-3 mice than in normal mice, as judged both by the 460-Id HI titer and by radioimmunoassay. On the other hand, the total anti-TNP response in normal and Id-3 mice was essentially the same and Id-3 mice immunized with TNP-levan displayed a proportion of El09 + anti-BL PFC which was similar to that of normal mice.
Enhancement of the 460-Ia ~-Component of the Anti-TNP Response in Id-3 Mice and in Normal Mice Pretreated with
Furthermore, when normal BALB/c mice were pretreated with three doses of 100 /~g of an ammonium sulfate fraction of anti-[anti-460-Id] antiserum, previously absorbed on a TNP-lysine-Sepharose-4B column, both the proportion of the 460-Id + anti-TNP PFC and the serum 460-Id concentration produced in response to TNP-NWSM were significantly increased (Table IV) . This result and that of the previous experiment indicate that anti-[anti°460-Id] antibodies enhance the number of anti-TNP PFC which secrete 460-Id + antibodies.
Absence of 460-Id-Specific Suppressor T Cells in Id-3 Mice.
In a previous study, we have shown that naturally occurring 460-Id-specific suppressor T cells regulate the activation of those cells potentially capable of producing 460-Id + anti-TNP antibodies. In the following experiment, we compared the suppressive effect of nylon woolenriched T lymphocytes from normal and Id-3 mice. Data presented in Table V Other instances in which an idiotype-anti-idiotype network has been employed to explore the role of such a mechanism in regulation should be mentioned. In one striking example, rabbit anti-Id antibody to anti-ribonuclease obtained from a single donor was prepared. Rabbits immunized to these anti-Id antibodies and then immunized with ribonuclease developed anti-ribonuclease antibodies with an idiotype similar to that expressed by the antibodies used to prepare the initial anti-Id antibody. Because sharing of idiotypes in anti-ribonuclease antibodies of normal rabbits is rarely observed (18) , these results suggest that immunization with anti-Id antibody perturbed the existing balance, either by directly activating Id-bearing B or T cells or by eliminating suppressor T cells which normally limited the expression of that idiotype. A similar observation has been made in response to certain polysaccharide antigens (19) .
These examples and our results give clear illustrations of the ways in which regulatory interactions among a network (20) of Id-bearing and Id-specific antibodies and cells might occur~ as well as emphasizing that second degree idiotype-anti-idiotype (Id-2-anti-Id-2) interactions could profoundly effect the expression of Id-I (e.g., 460-Id + anti-TNP antibodies) determinants on the antibodies produced as a result of 
